Anti-Kickback Indictments May Still Loom For Device Firms – Lawyer
This article was originally published in The Gray Sheet
Executive Summary
Medical device companies need to increase their compliance with the Anti-Kickback Statute to alleviate the risk of being targeted in federal probes, attorney John Reiss, PhD, maintains
You may also be interested in...
Anti-Kickback Statute, False Claims Act Increasingly Pursued By DoJ/OIG
Some legal problems associated with apparently false or misleading claims can be avoided if firms include a lay person's perspective in marketing discussions, U.S. District Attorney James Sheehan advised the Regulatory Affairs Professionals Society's annual meeting
Improper Device Reimbursement Coding Focus Of Federal Scrutiny – Attorneys
Device companies should be wary of reimbursement consultants engaged in "up-coding" - or increasing reimbursement rates by manipulating existing codes - as the government increasingly turns its attention to investigating device fraud
Device Firms May Be Held To OIG Pharmaceutical Compliance Standards
The HHS Office of the Inspector General's draft pharmaceutical industry compliance guide has relevance for device manufacturers, and demands their close scrutiny, health lawyers told participants during a recent Food & Drug Law Institute event